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THE NEED FOR HARM REDUCTION

Harm reduction:
1. A set of practical strategies and ideas aimed at reducing
negative consequences associated with drug use.
2. A movement for social justice built on a belief in, and
respect for, the rights of people who use drugs.

 In 2019 there were 96 fatal overdoses in Vermont

(prelim)

 86% of those overdoses involved fentanyl
 People engaged in medication-assisted treatment (MAT)

have lower mortality rate than those untreated

 People in MAT are better connected to other

prevention resources

 576 community-distributed naloxone kits were used to

reverse perceived overdose (2019, preliminary Q1-Q3)

 In a VT questionnaire, >50% of participants said that

they had never heard of fentanyl test strips and would
use them if they had them

PUBLIC HEALTH COST AND
COMMUNITY CONSIDERATIONS

 It is estimated that opiate use disorder (OUD) costs the

Medicaid system > $8 billion per year
 Costs society > $78 billion per year
 These costs have been rising over the past several years
 People with OUD seek more medical treatment, have longer

inpatient stays, require more interventions
 Lives of friends, family, neighbors, co-workers

COMMUNITY PERSPECTIVE AND SUPPORT
 Javad Mashkuri, MD is a physician in the CVMC ED. He

pioneered rapid access to MAT (RAM) in the CVMC ED.
He identified the need in our community and our ED
for better treatment for OUD. He is passionate about
meeting people where they’re at, no matter where they
are in their recovery. He feels strongly that addiction is
a disease and should be treated as so. He acknowledges
that people struggling with addiction have often been
mistreated, especially by the medical field. He wants
people to know that the ED is somewhere that they are
always welcome.
 Laurie Hanson is MAT nurse at CVMC. She sees the

need for naloxone in remote Vermont locations that are
far from emergency medical services and is excited to
see its impact.

 Theresa Vezina works for Vermont Cares, a non-

profit focused on prevention, welling being, and
harm reduction. She is passionate about all things
harm reduction. She really listens to clients when
she meets with them and works with them to
meet their needs. She believes that ”a harm
reduction philosophy could be implemented in all
sectors of social and health services. “ She would
love to see “expanded access in less stigmatizing
settings,” “harm reduction interventions for noninjecting persons,” and “more support for
families to teach them about harm reduction.”

INTERVENTION/METHODOLOGY
 Production and distribution of harm reduction kits


Supplies: Narcan, fentanyl test strips, sterile water, condoms,
alcohol swab, gloves



Literature surrounding: safer use, local resources, overdose
awareness and response, how to use fentanyl strips

 Harm reduction training for recovery coaches
 Harm reduction training for nursing staff in the Emergency

Department
 Collaborative effort with Washington County Substance

Abuse Partnership (WCSAP) and CVMC MAT team

RESULTS/RESPONSE
 Increased awareness among ED and Turning Point staff

of harm reduction definition, implementation, and local
resources

 Availability of harm reduction kits to patients in the

ED and CVMC Madriver MAT

 Increased community awareness of safer use practices

and local resources and treatment option

 Community members who are more informed and

better equipped to keep themselves healthy

 (Hopeful) More members of our community living

longer healthier lives

EFFECTIVENESS/LIMITATIONS
Ways to measure effect:
 Qualitative evaluation by feedback of harm reduction

kit recipients

 Qualitative feedback from recovery coaches and

nursing staff

 Quantitative evaluation comparing drug-associated

ED admissions and medical interactions before and
after implementation

 Quantitative evaluation by incorporating intake

inquiry at VT Cares and other local treatment
centers

Limitations:
 In early stages of distribution
 Difficult group of patients to follow

 Multiple reasons for seeking medical care related to

drug use

 Could hinder therapeutic relationships by over-

polling

RECOMMENDATIONS FOR FUTURE INTERVENTION/PROJECT
 Widening distribution of harm reduction kits to more CVMC sites
 Widening harm reduction education to other CVMC sites
 Data collection surrounding use of fentanyl strips, Narcan, and other harm reduction items
 Comparison of pre-administration drug-related healthcare visits and post-administrative visits
 Tracking behavior change following harm reduction kit acquisition
 Chart review of most common drug-related medical problems within our network
 Implementation of syringe service
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